Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
OVERLAP
28%
OVERLAP
BY WEIGHT
5
# OF OVERLAPPING
HOLDINGS
MEDI
37
HOLDINGS
15%
ALSO IN PPH
PPH
27
HOLDINGS
21%
ALSO IN MEDI
SECTOR DRIFT (MEDI minus PPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in MEDI |
Weight in PPH |
Overlap | |
|---|---|---|---|---|
| ELI LILLY & CO | 20.3% | 18.8% | 18.8% | |
| ABBVIE INC | 3.5% | 4.7% | 3.5% | |
| MERCK & CO. INC. | 2.3% | 11.0% | 2.3% | |
| CENCORA INC | 2.0% | 3.8% | 2.0% | |
| NOVO-NORDISK A/S-SPONS ADR | 1.2% | 4.8% | 1.2% | |
MEDI Overweight Relative to PPH
| GILEAD SCIENCES INC | 4.4% | |
| LEGEND BIOTECH CORPORATION SPONSORED | 4.4% | |
| RHYTHM PHARMACEUTICALS, INC. | 4.1% | |
| INTUITIVE SURGICAL INC | 3.4% | |
| ABIVAX SA-ADR | 3.1% | |
| INSMED INC | 2.9% | |
| BOSTON SCIENTIFIC CORP | 2.7% | |
| REVOLUTION MEDICINES, INC. | 2.6% | |
| NATERA INC | 2.5% | |
| VAXCYTE, INC. | 2.1% |
MEDI Underweight Relative to PPH
| NOVARTIS AG-ADR | -9.3% | |
| MERCK & CO. INC. | -8.8% | |
| PFIZER INC | -5.2% | |
| BRISTOL-MYERS SQUIBB CO | -4.9% | |
| MCKESSON CORP | -4.8% | |
| JOHNSON & JOHNSON | -4.6% | |
| GLAXOSMITHKLINE PLC-SPON ADR | -4.1% | |
| SANOFI-AVENTIS-ADR | -4.0% | |
| ASTRAZENECA PLC-SPONS ADR | -3.7% | |
| NOVO-NORDISK A/S-SPONS ADR | -3.6% |